Advertisement
Product › Details
OPTI LION portable eclectrolyte analyser
Next higher product group | OPTI (product series) | |
Status | 2005-10-04 registration start | |
Organisation | Osmetech plc (LSE: OMH) | |
Group | Roche (Group) | |
Record changed: 2023-07-10 |
Advertisement
More documents for diagnostic device
- [1] NLC Ventures Netherlands B.V.. (10/5/22). "Press Release: Crainio, an NLC Venture, Sets Out to Revolutionise the Measurement of Intracranial Pressure (ICP) by Developing a Non-invasive Measuring Device"....
- [2] Scienion GmbH. (7/5/22). "Press Release: Highfield Diagnostics and Scienion Sign Memorandum of Understanding". Southampton & Berlin....
- [3] Owlstone Medical Ltd.. (9/7/21). "Press Release: Owlstone Medical Closes $58 Million USD (c. £42 Million GBP) Oversubscribed Financing Round to Continue to Advance Breath Biopsy". Cambridge....
- [4] Lunaphore Technologies S.A.. (6/15/20). "Press Release: Epredia and Lunaphore Announce Commercial Agreement for Exclusive Distribution of LabSat Research". Portsmouth, NH & Lausanne....
- [5] Owlstone Medical Ltd.. (3/30/20). "Press Release: Owlstone Medical Appoints Neil Tween as Chief Financial Officer". Cambridge....
- [6] Randox Laboratories Ltd.. (3/26/20). "Press Release: Point of Care Coronavirus Test from Randox and Bosch Will Launch in April 2020"....
- [7] Owlstone Medical Ltd.. (12/10/19). "Press Release: Owlstone Medical to Join EU-Funded EPHOR Consortium to Advance Occupational Health Science in Order to Reduce Disease Burden from Workplace Exposure". Cambridge....
- [8] Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge....
- [9] UCL Technology Fund. (9/16/19). "Press Release: Echopoint Raises £2.8m to Address the ‘Grey Zone’ of Heart Disease treatment"....
- [10] Owlstone Medical Ltd.. (6/18/19). "Press Release: Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease". Cambridge....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top